Envveno Medical Corp Stock Today
| NVNO Stock | USD 2.90 0.04 1.40% |
PerformanceWeak
| Odds Of DistressLow
|
EnVVeno Medical is selling at 2.90 as of the 21st of March 2025; that is 1.40% increase since the beginning of the trading day. The stock's open price was 2.86. EnVVeno Medical has about a 21 % chance of experiencing some form of financial distress in the next two years of operation and did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 21st of December 2024 and ending today, the 21st of March 2025. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 31st of May 2018 | Category Healthcare | Classification Health Care |
enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company was formerly known as Hancock Jaffe Laboratories, Inc. The company has 17.54 M outstanding shares of which 427.14 K shares are now shorted by private and institutional investors with about 5.4 trading days to cover. More on enVVeno Medical Corp
Moving together with EnVVeno Stock
Moving against EnVVeno Stock
| 0.31 | INBX | Inhibrx Symbol Change | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
EnVVeno Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| Thematic Ideas | (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, Drugs, Medical Equipment, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsEnVVeno Medical can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand EnVVeno Medical's financial leverage. It provides some insight into what part of EnVVeno Medical's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
enVVeno Medical Corp (NVNO) is traded on NASDAQ Exchange in USA. It is located in 70 Doppler, Irvine, CA, United States, 92618 and employs 37 people. EnVVeno Medical is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 50.15 M. enVVeno Medical Corp conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 17.54 M outstanding shares of which 427.14 K shares are now shorted by private and institutional investors with about 5.4 trading days to cover.
enVVeno Medical Corp currently holds about 37.48 M in cash with (16.84 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.96, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check EnVVeno Medical Probability Of Bankruptcy
Ownership AllocationEnVVeno Medical holds a total of 17.54 Million outstanding shares. Nearly 74.71 percent of EnVVeno Medical outstanding shares are held by general public with 0.92 (percent) owned by insiders and only 24.37 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check EnVVeno Ownership Details
EnVVeno Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Northern Trust Corp | 2024-12-31 | 56.7 K | |
| Hohimer Wealth Management, Llc | 2024-12-31 | 51.3 K | |
| Marshall Wace Asset Management Ltd | 2024-12-31 | 48.8 K | |
| Squarepoint Ops Llc | 2024-12-31 | 47.9 K | |
| State Street Corp | 2024-12-31 | 40.8 K | |
| Blackrock Inc | 2024-12-31 | 40.6 K | |
| Quadrature Capital Llp | 2024-12-31 | 39.2 K | |
| Fermata Advisors, Llc | 2024-12-31 | 35.7 K | |
| Virtu Financial Llc | 2024-12-31 | 28.5 K | |
| Kingdon Capital Management Llc | 2024-12-31 | 859.3 K | |
| Nantahala Capital Management, Llc | 2024-12-31 | 596.9 K |
EnVVeno Medical Historical Income Statement
EnVVeno Stock Against Markets
EnVVeno Medical Corporate Management
| Andrew Cormack | Chief Officer | Profile | |
| Craig Glynn | Treasurer CFO | Profile | |
| Benedict MD | Chief States | Profile | |
| Sandy Prietto | Vice Marketing | Profile | |
| Robert Berman | CEO Director | Profile | |
| Marc MD | Senior Officer | Profile | |
| Hamed Alavi | Senior Officer | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in enVVeno Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EnVVeno Medical. If investors know EnVVeno will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EnVVeno Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of enVVeno Medical Corp is measured differently than its book value, which is the value of EnVVeno that is recorded on the company's balance sheet. Investors also form their own opinion of EnVVeno Medical's value that differs from its market value or its book value, called intrinsic value, which is EnVVeno Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EnVVeno Medical's market value can be influenced by many factors that don't directly affect EnVVeno Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EnVVeno Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if EnVVeno Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EnVVeno Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.